1. 1-24 of 512 1 2 3 4 ... 20 21 22 »
    1. 22nd Century Appoints Leading Plant Biotechnology Expert Dr. Michael Koganov to Board of Directors

      22nd Century Appoints Leading Plant Biotechnology Expert Dr. Michael Koganov to Board of Directors

      WILLIAMSVILLE, N.Y., Sept. 17, 2020 (GLOBE NEWSWIRE) -- 22nd Century Group, Inc. (NYSE American: XXII) (“22nd Century” or “the Company”), a leading plant-based, life science company driven by next generation plant biotechnology, today announced the appointment of Michael Koganov, Sc.D., Ph.D., to its Board of Directors...

      Read Full Article
    2. Cue Biopharma Welcomes Tamar Howson to its Board of Directors

      Cue Biopharma Welcomes Tamar Howson to its Board of Directors

      CAMBRIDGE, Mass., Sept. 17, 2020 (GLOBE NEWSWIRE) -- Cue Biopharma, Inc. (NASDAQ: CUE), a clinical-stage biopharmaceutical company engineering a novel class of injectable biologics to selectively engage and modulate targeted T cells within the body, announced today the appointment of Tamar Howson to its board of directors...

      Read Full Article
    3. Elizabeth Montoya Appointed to Rubicon’s Board of Directors

      Elizabeth Montoya Appointed to Rubicon’s Board of Directors

      Rubicon, a software company that provides smart waste and recycling solutions to businesses and governments worldwide, announced today that Elizabeth Montoya, the company’s current Chief of Protocol and Investor Relations, and key advisor to the CEO, has been appointed to Rubicon’s Board of Directors, effective immediately...

      Read Full Article
    4. Prevail Therapeutics Announces Appointment of William H. Carson, M.D., to Board of Directors

      Prevail Therapeutics Announces Appointment of William H. Carson, M.D., to Board of Directors

      NEW YORK, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases, today announced the appointment of William H. Carson, M.D., to its Board of Directors...

      Read Full Article
    5. Anika Announces Appointment of Jack Henneman and Stephen Richard to Board of Directors

      Anika Announces Appointment of Jack Henneman and Stephen Richard to Board of Directors

      EDFORD, Mass., Sept. 08, 2020 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global, integrated joint preservation, restoration and regenerative solutions company with products across the orthopedic early intervention continuum of care, today announced that Anika’s Board of Directors has appointed John B. Henneman, III (“Jack”) and Stephen Richard as independent directors...

      Read Full Article
    6. Election of Lisa G. McMahon as Chairperson of Western New England Bancorp Board of Directors Highlights Board’s Commitment to Diversity

      Election of Lisa G. McMahon as Chairperson of Western New England Bancorp Board of Directors Highlights Board’s Commitment to Diversity

      WESTFIELD, Mass., Sept. 03, 2020 (GLOBE NEWSWIRE) -- Western New England Bancorp (NasdaqGS: WNEB) is pleased to announce that on March 24, 2020, Lisa G. McMahon of Westfield was elected Chairperson of Western New England Bancorp’s Board of Directors...

      Read Full Article
    7. Diffusion Pharmaceuticals Appoints Jane H. Hollingsworth to its Board of Directors

      Diffusion Pharmaceuticals Appoints Jane H. Hollingsworth to its Board of Directors

      CHARLOTTESVILLE, Va., Sept. 01, 2020 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (“Diffusion” or “the Company”), a biotechnology company developing new treatments for life-threatening medical conditions by improving the body’s ability to deliver oxygen to the areas where it is needed most, today announced the appointment of Jane H. Hollingsworth to its board of directors...

      Read Full Article
    8. Akoustis Appoints Former Grant Thornton, CEO, J. Michael McGuire, to its Board of Directors

      Akoustis Appoints Former Grant Thornton, CEO, J. Michael McGuire, to its Board of Directors

      Charlotte, N.C., Sept. 02, 2020 (GLOBE NEWSWIRE) -- Akoustis Technologies, Inc. (NASDAQ: AKTS) (“Akoustis” or the “Company”), an integrated device manufacturer (IDM) of patented bulk acoustic wave (BAW) high-band RF filters for mobile and other wireless applications, announced today that it has appointed J. Michael McGuire, CPA, as a new member of its board of directors...

      Read Full Article
      Mentions: Nasdaq Board CEO
    1-24 of 512 1 2 3 4 ... 20 21 22 »
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Question of The Week, Sponsored Content